ACTRN12610000483055招募中2 期
Randomised placebo controlled study of vitamin D3 during pregnancy and infancy to determine the vitamin D dose in pregnancy and early life that safely and effectively increases serum vitamin D concentration in infants.
niversity of Auckland0 个研究点目标入组 260 人开始时间: 2010年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- Female
入选标准
- •Pregnant women who are intending to delivery at Middlemore Hospital and who are either public patients attending the antenatal clinics at Middlemore hospital or whose lead maternity caregiver is a member of South Auckland Maternity Care Limited (SAMCL) will be invited to take part in the study during antenatal visits.
排除标准
- •We will exclude pregnant mothers taking vitamin D supplementation that exceeds 200 IU/day & those with a history of renal stones or hypercalcaemia or found to be hypercalcaemic at enrolment. We will also exclude any serious complication of pregnancy at the time of enrolment.
研究者
相似试验
进行中（未招募）
不适用
A randomized placebo controlled trial of vitamin D3 supplementation to a vulnerable patientsgroup susceptible to uppertract respiratory infections.Patients with primary or secondary immunodeficiencies and/or patients who have an increased incidence of airborn infections more than 42 infectionsday /year.EUCTR2009-011758-16-SEKarolinska University Hospital Huddinge
尚未招募
4 期
Vitamin D3 Supplementation On Level Of Blood Glucose Among Vitamin D Deficient Adult With Prediabetes.CTRI/2014/12/005290A Rathiga288
进行中（未招募）
1 期
Prospective, placebo-controlled trial of vitamin D supplementation in patients with low-levels of 25-OH vitamin D to evaluate changes in markers of cardiovascular riskEUCTR2007-007474-33-ATDr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin100
进行中（未招募）
1 期
Placebo controlled study on effects of vitamin D supplementation in healthy women and men on immunological, endocrine and metabolic parametershealthy volunteers. The intended indication for the investigated product is prevention and treatment of immunological (e.g. type 1 diabetes), endocrine (e.g. endocrine hypertension), metabolic (e.g. dyslipidemia) and cardiovascular diseases.EUCTR2009-015523-91-ATMedizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin
进行中（未招募）
不适用
Placebo controlled study on effects of vitamin D supplementation in type 1 diabetic subjects on immunological, endocrine and metabolic parameters: Step 2 of the Austrian Diabetes Prevention Programme (ADPP-002)To evaluate whether vitamin D supplementation in type 1 diabetic subjects significantly alters the proportion of regulatory T-cells of all circulating CD4 positive T-cells.EUCTR2010-018901-12-ATMedical University Graz, Department of Internal Medicine, Div. Endocrinology and Metabolism